Injectable peptides go mainstream on social media

A class of “injectable peptides” marketed online as a quick “glow up” is moving from gym and biohacker forums into mainstream social media feeds, with influencers claiming benefits that range from clearer skin and thicker hair to pain relief and treatment of chronic infections. According to The Guardian, many of the products being promoted are sold through unregulated channels and explicitly labelled for “research use”, not approved for human use. Yet the trend has gained enough cultural and political traction that US health secretary Robert F Kennedy Jr has said he will approve the sale of “about 14” injectable peptide drugs to the public.

Peptides are not a single category of harmless supplements. Some are naturally occurring signalling molecules—hormone-like messengers that can alter basic metabolic and immune functions. The best-known example is the GLP‑1 class, which underpins drugs such as Ozempic and Wegovy. That success has created a halo effect: the public now recognises the word “peptide” as modern medicine, while social platforms treat it as lifestyle content. The Guardian quotes Australian Medical Association public health chair Michael Bonning warning that most therapeutic peptides are prescription-only and that buying injectables online bypasses the quality controls that make medicines predictable.

The business model is straightforward. Influencers sell identity and status—before-and-after narratives, “protocols”, and the promise of insider access. Grey-market sellers sell availability: small vials, direct shipping, and the implied freedom to self-experiment without gatekeepers. For regulators, the timeline is backwards. By the time agencies respond, a user base exists, money has changed hands, and harms—if they emerge—are diffuse and hard to attribute. The Guardian notes that even if a peptide had some evidence behind it, buyers still cannot be sure what is actually in the vial or whether it was manufactured to a standard safe for injection.

That uncertainty is where liability becomes slippery. If someone is harmed, the platform can point to “user-generated content”, the influencer can point to disclaimers, the seller can point to “research use only”, and the consumer is left holding the needle. The same ambiguity that helps content travel—short videos, casual testimonials, and repeatable scripts—also helps responsibility evaporate. Bonning warns that some injectable peptides promoted online, including tanning peptides, have been associated in reports with serious outcomes such as kidney dysfunction and swelling of the brain.

The platforms did not create injectable drugs, but they have become the demand engine for them. The fastest-growing part of the supply chain is the part that never has to prove what it is selling.